Haemonetics Initiated at Overweight by JP Morgan
Haemonetics Analyst Ratings
Analysts Offer Insights on Healthcare Companies: Haemonetics (HAE) and Terns Pharmaceuticals (TERN)
Barrington Maintains Haemonetics(HAE.US) With Buy Rating, Maintains Target Price $108
Haemonetics Corporation: Strategic Divestment and Innovation Drive Buy Rating With $125 Target
Haemonetics Is Maintained at Outperform by Barrington Research
Haemonetics Analyst Ratings
Analysts Are Bullish on Top Healthcare Stocks: Haemonetics (HAE), Alcon (ALC)
Haemonetics Analyst Ratings
Needham Maintains Haemonetics(HAE.US) With Buy Rating, Maintains Target Price $112
Strategic Investment and Growth Potential Drive Buy Rating for Haemonetics
Raymond James Maintains Haemonetics(HAE.US) With Buy Rating, Maintains Target Price $120
A Quick Look at Today's Ratings for Haemonetics(HAE.US), With a Forecast Between $108 to $125
Haemonetics Is Maintained at Outperform by Barrington Research
Analysts' Opinions Are Mixed on These Healthcare Stocks: AMN Healthcare Services (AMN), DENTSPLY SIRONA (XRAY) and Haemonetics (HAE)
A Quick Look at Today's Ratings for Haemonetics(HAE.US), With a Forecast Between $112 to $125
Haemonetics Analyst Ratings
Haemonetics Earns Buy Rating for Strong Q2 Performance and Margin Improvements
Haemonetics Is Maintained at Outperform by Barrington Research
Barrington Maintains Haemonetics(HAE.US) With Buy Rating, Maintains Target Price $108